Imperative Care

Imperative Care is a private, commercial-stage medical device innovator targeting the high-burden areas of stroke and vascular thrombectomy. The company has established a commercial foundation with its Zoom Stroke System and Vascular portfolio (Symphony and Prodigy) for clot removal in ischemic stroke, venous thromboembolism (VTE), and acute limb ischemia (ALI). Strategically, it is investing in future growth through the development of the Telos robotic platform, aiming to standardize procedures and expand geographic access to interventional care. The company's mission centers on elevating patient outcomes by tackling systemic inefficiencies from diagnosis through treatment.

Integrated procedural platform for mechanical thrombectomy, including specialized device systems for neurovascular and peripheral vascular applications and an investigational endovascular robotics platform (Telos) for procedural precision and access expansion.

Imperative Care competes in the crowded and well-established thrombectomy device market, facing off against major players like Medtronic, Stryker, Johnson & Johnson, and Penumbra. Its differentiation is based on system design for specific vascular beds (stroke, vein, artery) and its future robotic platform. In robotics, it would compete with early systems from Siemens Healthineers, Corindus (Siemens), and other emerging entrants in the neuro-interventional space.